Why a Third-Generation Ophthalmologist Built a Better AREDS2 Supplement
Written by Dr. Louis Michaelos, Ophthalmologist & Founder, MacuRest | Board-certified ophthalmologist, Tampa Bay area | Last reviewed May 2026
MacuRest exists because every AREDS2 supplement on the market was designed for daytime oxidative protection — and none of them addressed the overnight repair window, which is when the retina is most actively maintaining itself.
Why MacuRest Exists
MacuRest was created by Dr. Louis Michaelos, a third-generation ophthalmologist practicing in the Tampa Bay area. The clinical evidence from the National Eye Institute's AREDS2 trial is unambiguous: this specific nutrient combination reduces the risk of AMD advancing to late stages by approximately 25% in the appropriate patient population. But something kept bothering him.
The Gap Nobody Was Addressing
The AREDS2 formula was designed around daytime oxidative protection. What it did not address was what happens at night. During sleep, the retinal pigment epithelium performs intensive maintenance — breaking down and replacing worn outer segments in a process called phagocytosis, documented in Webvision (NCBI). In AMD, this progressively degrades. And not a single AREDS2 supplement addressed this overnight window. Meanwhile, a landmark 2024 study in JAMA Ophthalmology found melatonin users had significantly lower AMD progression rates across 100,000+ patients.
Read more: What do clinical trials say about melatonin and eye health?
The Formula That Resulted
MacuRest combines the complete AREDS2-inspired clinical formula with melatonin 5mg and B-complex vitamins, taken each evening with dinner when fat-soluble nutrients absorb best and melatonin works with the body's natural circadian rhythm.
Learn more: How MacuRest works | MacuRest vs other eye vitamins | Frequently asked questions
Frequently Asked Questions
Who created MacuRest?
MacuRest was created by Dr. Louis Michaelos, a board-certified third-generation ophthalmologist practicing in the Tampa Bay area, FL, with over 20 years of clinical experience treating patients with age-related macular degeneration. He developed MacuRest after years of recommending standard AREDS2 supplements and identifying the gap in overnight retinal repair support.
Why did an ophthalmologist create an eye supplement?
Dr. Michaelos saw firsthand that standard AREDS2 supplements — while clinically validated for daytime macular protection — addressed none of the overnight retinal repair cycle. Emerging research on melatonin's role in retinal maintenance, combined with the 2024 JAMA Ophthalmology findings, led him to formulate a supplement that addressed both windows in a single evening dose.
What makes MacuRest different from other AREDS2 supplements?
MacuRest is the only AREDS2-inspired supplement specifically designed for evening use. It combines the full six-nutrient AREDS2 clinical formula with melatonin 5mg for overnight retinal repair support, uses 25mg zinc for daily tolerability (vs. 80mg in standard formulas that causes GI side effects), and was formulated by a practicing ophthalmologist rather than a supplement company.
Is MacuRest endorsed by ophthalmologists?
MacuRest was formulated by Dr. Louis Michaelos, a board-certified ophthalmologist. It is not a product of a supplement marketing company. Dr. Michaelos developed it based on the same clinical criteria he applies when evaluating supplements for his own patients.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.